Clinical Trials Directory

Trials / Completed

CompletedNCT01141998

Vitamin D Substitution for Patients With Chronic Pancreatitis and Malabsorption

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Purpose: The overall objective of this study is to learn more about the disease chronic pancreatitis and thus contribute to better treatments. The investigators will gain this by studying the effects of vitamin D in the body immune system and bones. The investigators will also study the uptake of vitamin D through the intestine compared with the amount of vitamin D obtained through exposure to UVB rays. The investigators have set a series of questions which the investigators want to answer with this experiment: Do patients with chronic pancreatitis have reduced absorption of vitamin D from the gut? * Have the two treatment methods with vitamin D, UV radiation and tablets, the same success rate? * Does the distribution of the white blood cells change when the vitamin D level increases and does it depend on whether the patient have UVB radiation or tablet with vitamin D? * Will patients require reduced amounts of painkillers when vitamin D level increases? * Does vitamin D have influence on blood sugar and thus the risk of diabetes or worsening of this? * Could vitamin D affect the blood content of inflammation markers? * Does the patient feel better when he takes vitamin D? * Does bone strength increase when the patients receive grants of vitamin D?

Conditions

Interventions

TypeNameDescription
DRUGCalcium, Dietary400 mg calcium two times daily. From week 0 to 10 and week 14 to 52.
DRUGCholecalciferol38 micrograms daily. Week 0-10.
RADIATIONUVBUltraviolet radiation type B administered in a tanning bed. One time weekly.
RADIATIONUV-filtered light.Light from a tanning bed but a UV-filter stops all ultraviolet radiation. One time weekly.
DRUGCholecalciferol38 micrograms daily. From week 14 to 52.

Timeline

Start date
2009-12-01
Primary completion
2010-05-01
Completion
2011-03-01
First posted
2010-06-11
Last updated
2011-12-23

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01141998. Inclusion in this directory is not an endorsement.